Bowel ischemia in COVID‐19: A systematic review

Authors:

Abstract
Background Gastrointestinal complications of this COVID-19 have been reported over the last year. One such manifestation is bowel ischemia. This study thus aims to provide a more holistic review of our current understanding of COVID-19 induced bowel ischemia. Method and Results A meticulous search was performed using different keywords in PubMed and Google Scholar. Fifty-two articles were included in our study after applying inclusion and exclusion criteria and performing the qualitative assessment of the studies. A total of 25,702 patients were included in our study after the completion of the qualitative assessment. Discussion COVID-19 commonly presents in the GIT as diarrhea, vomiting, nausea, and abdominal pain. The mechanism of bowel ischemia is associated with the formation of emboli which is related to COVID-19’s high affinity for angiotensin-converting enzyme-2 on enterocytes, affecting the superior mesenteric vessels. Clinically, patients presented with abdominal pain and vomiting. CT angiography of the abdomen and pelvis showed acute intestinal ischemia (mesenteric). Management is usually initiated with gastric decompression, fluid resuscitation, and hemodynamic support. Surgical intervention is also sought. Conclusion Intestinal ischemia presenting in patients with COVID-19 has to be considered when symptoms of severe abdominal pain are present. More research and guidelines are required to be able to triage patients with COVID-19 to suspect intestinal ischemia and to help in diagnosis and management.

This publication has 46 references indexed in Scilit: